Funding and support

The Editoral Base of Cochrane Haematology (CH)  is funded under the auspices of the German Federal Ministry of Education and Research (BMBF), Deutsche Krebshilfe e.V.,  European Heamatology Association (EHA), Institute for Quality and Efficiency in Healthcare (IQWIG)European Respiratory Society (ERS)World Health Organization (WHO)Deutschen Forschungsgemeinschaft (DFG), in addition by the funding programme Köln Fortune from the medical faculty University of Cologne.

The following projects are currently funded by the German Federal Ministry of Education and Research:

  • Prognostic models for chronic lymphocytic leukaemia: an exemplar systematic review and meta-analysis (BMBF grant application, No: 01KG1711)

  • Bisphosphonates or RANK-ligand-inhibitors for patients with prostate cancer and bone metastases: A Cochrane systematic review and network meta-analysis (BMBF grant application, No: 01KG1702)

  • First-line therapy for adult patients with advanced renal cell carcinoma: a living systematic review (BMBF grant application, No: 01KG1901)

  • Bone -modifying agents for the prevention of bone loss in women with early or locally advanced breast cancer: a systematic review and network meta-analysis (BMBF grant application, No: 01KG1806)

The following projects are funded by the German Cancer Aid:

  • Update of the interdisciplinary evidence-based guideline for Hodgkin´s Lymphoma in Adults, diagnosis, treatment and follow-up (Funding provided by the German Cancer Aid)

  • Interdisciplinary evidence-based guideline for diagnosis, therapy and follow-up of multiple myeloma patients (Funding provided by the German Cancer Aid)

  • Interdisciplinary evidence-based guideline for diagnosis, therapy and follow-up of mature patients with diffuse large B-cell-lymphoma (Funding provided by the German Cancer Aid)

  • Interdisciplinary evidence-based guideline: Thyroid carcinoma (Funding provided by the German Cancer Aid)

The following projects are currently funded by the DFG:

  • Assessment of the current status of the special features of time-to-event analyzes in meta-analyszes: re-analysis of systematic reviews and implementation of instructions (Funding by the DFG, SK 146/2-1)

The following project is currently funded by the ERS:

  • Non-CPAP Therapies for Obstructive Sleep Apnoea (Funding by the ERS, TF-2018-01)

The following project is currently funded by the EHA:

  • Antifungal prophylaxis and therapy in patients with acute myeloid leukaemia treated with new agents (Funding provided by the EHA)

The following project is currently funded by the IQWIG:

  • Autologous chondrocyte implantation at the knee joint

The following project is currently funded by the Cochrane Network Innovation Fund 2019:

  • Instructions for inclusion and presentation of time-to-event outcomes in Cochrane Intervention Reviews – development of training resources